Balance Sheet

v3.26.1

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Mar. 31, 2025
Current assets:
Cash and cash equivalents	$ 902,110	$ 713,971
Accounts receivable	1,133	2,084
Prepaid expenses and other current assets	42,763	51,180
Income tax receivable	2,813	427
Total current assets	948,819	767,662
Operating lease right-of-use assets	72	98
Property and equipment, net	443	844
Other assets	7,680	7,618
Total assets	957,014	776,222
Current liabilities:
Accounts payable	7,541	17,656
Accrued expenses	96,634	50,748
Current portion of operating lease liabilities	72	98
Due to Roivant Sciences Ltd.	175	273
Total current liabilities	104,422	68,775
Total liabilities	104,422	68,775
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 203,940,353 shares issued and outstanding at March 31, 2026 and 500,000,000 shares authorized, 170,111,593 shares issued and outstanding at March 31, 2025	20	16
Additional paid-in capital	2,596,971	1,945,495
Accumulated other comprehensive income	730	1,459
Accumulated deficit	(1,745,129)	(1,239,523)
Total stockholders’ equity	852,592	707,447
Total liabilities and stockholders’ equity	957,014	776,222
Series A preferred stock
Stockholders’ equity:
Preferred stock	0	0
Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source